<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00551941</url>
  </required_header>
  <id_info>
    <org_study_id>2007/341</org_study_id>
    <nct_id>NCT00551941</nct_id>
  </id_info>
  <brief_title>A Prospective Randomized Controlled Trial on the Use of Bone Morphogenetic 7 (BMP-7) (OP-1®) and Demineralized Bone Matrix in Tibial Non-union</brief_title>
  <official_title>A Prospective Randomised Controlled Trial on the Use of BMP-7 (OP-1®) and Demineralised Bone Matrix in Tibial Non-union</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Ghent</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Ghent</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The researchers propose a prospective, randomised partially-blinded study to investigate the&#xD;
      clinical and radiological outcome, effect on quality of life and socio-economic impact of&#xD;
      non-union of diaphysary tibial fractures treated with BMP-7 in adjunct to fresh frozen&#xD;
      allograft, in comparison to treatment with allograft together with DBM (demineralised bone&#xD;
      matrix).&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Recruitment problems&#xD;
  </why_stopped>
  <start_date type="Actual">October 2007</start_date>
  <completion_date type="Actual">July 9, 2012</completion_date>
  <primary_completion_date type="Actual">July 9, 2012</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>X-ray evaluation</measure>
    <time_frame>After 9 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in VAS and LEFS scores</measure>
    <time_frame>After 9 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Time of incapacity to work</measure>
    <time_frame>Until ability to work</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in SF-36</measure>
    <time_frame>After 4 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total socio-economic cost estimation</measure>
    <time_frame>After 4 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Repeated surgery (minor and major)</measure>
    <time_frame>After 4 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>(Surgical) complications</measure>
    <time_frame>After 4 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ability to bear weight (% of body weight)</measure>
    <time_frame>After 4 years</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">2</enrollment>
  <condition>Non-union Diaphysary Tibial Fractures</condition>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>non-union of diaphysary tibial fractures will be treated with allograft together with DBM</description>
  </arm_group>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>non-union of diaphysary tibial fractures will be treated with BMP-7 in adjunct to fresh frozen allograft</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>BMP-7 in adjunct to fresh frozen allograft</intervention_name>
    <description>non-union of diaphysary tibial fractures treated with BMP-7 in adjunct to fresh frozen allograft</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>allograft together with DBM</intervention_name>
    <description>non-union of diaphysary tibial fractures treated with allograft together with DBM</description>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Diaphysary tibial non-unions will be included (9 months after first surgery)&#xD;
&#xD;
          -  Major surgery includes exchange nailing, bone grafting, internal fixation, amputation&#xD;
             and soft-tissue coverage procedures, such as delayed primary closure and free flaps&#xD;
&#xD;
          -  Surgery is classified as minor for removal of external fixator pins for local&#xD;
             infection and removal of a static locking screw from intramedullary nails, a procedure&#xD;
             known as dynamization&#xD;
&#xD;
          -  ASA 1 and ASA 2&#xD;
&#xD;
          -  Gap length/bone contact detected (1-5 cm): largest cortical gap in any radiographic&#xD;
             incidence&#xD;
&#xD;
          -  Subject or legal guardian is willing and able to understand, sign and date the study&#xD;
             specific Patient Informed Consent, which has been approved by the Institutional Review&#xD;
             Board&#xD;
&#xD;
          -  Agrees to participate in post-operative evaluations and required rehabilitation&#xD;
             regimen&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients with known hypersensitivity to the active substance or collagen&#xD;
&#xD;
          -  Gap more than 5 cm&#xD;
&#xD;
          -  Immature skeleton&#xD;
&#xD;
          -  Known auto-immune disease, including rheumatoid arthritis, systemic lupus&#xD;
             erythematosus, scleroderma, Sjögren's syndrome and dermatomyositis/polymyositis&#xD;
&#xD;
          -  Active infection on unhealed site or active systemic infection&#xD;
&#xD;
          -  Non-healing resulting from pathological fractures, tumours or metabolic bone diseases&#xD;
&#xD;
          -  Presence of tumour in vicinity of non-union&#xD;
&#xD;
          -  Patients receiving chemotherapy, radiotherapy or immunosuppressant treatment or&#xD;
             excessive steroids&#xD;
&#xD;
          -  Patients with severely compromised soft tissue coverage or vascularisation at the&#xD;
             non-union site, sufficient to impair bone healing&#xD;
&#xD;
          -  Patients with congenital non-union&#xD;
&#xD;
          -  Pregnancy and lactation&#xD;
&#xD;
          -  Non-union of multiple bones interfering with walking&#xD;
&#xD;
          -  Patients with neuromuscular diseases or conditions interfering normal weight bearing&#xD;
&#xD;
          -  Patients who, judged by the surgeon, are candidates for just internal fixation alone&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Rene Verdonk, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Ghent</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>AZ Sint Jan-Brugge</name>
      <address>
        <city>Brugge</city>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital Ghent</name>
      <address>
        <city>Ghent</city>
        <zip>9000</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>October 30, 2007</study_first_submitted>
  <study_first_submitted_qc>October 31, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 1, 2007</study_first_posted>
  <last_update_submitted>July 7, 2021</last_update_submitted>
  <last_update_submitted_qc>July 7, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 8, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tibial Fractures</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

